AGE-breakers cleave model compounds, but do not break Maillard crosslinks in skin and tail collagen from diabetic rats (Q44368321)

2 December 2017

AGE-breakers cleave model compounds, but do not break Maillard crosslinks in skin and tail collagen from diabetic rats (English)

1 reference

2 December 2017

Shengzu Yang

1

1 reference

2 December 2017

John E Litchfield

series ordinal

2

1 reference

2 December 2017

John W Baynes

series ordinal

3

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

Archives of Biochemistry and Biophysics

2 December 2017

1 reference

2 December 2017

412

1 reference

2 December 2017

42-46

1 reference

2 December 2017

1

1 reference

Role of the Maillard reaction in diabetes mellitus and diseases of aging

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900015-8

Protein glycation, diabetes, and aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900015-8

Biological effects of aminoguanidine: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900015-8

Therapeutic potential of AGE inhibitors and breakers of AGE protein cross-links

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900015-8

Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900015-8

Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900015-8

An agent cleaving glucose-derived protein crosslinks in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900015-8

Rapid hydrolysis and slow α,β-dicarbonyl cleavage of an agent proposed to cleave glucose-derived protein cross-links

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900015-8

Effects of advanced glycation end-product inhibition and cross-link breakage in diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900015-8

N-phenacylthiazolium bromide decreases renal and increases urinary advanced glycation end products excretion without ameliorating diabetic nephropathy in C57BL/6 mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900015-8

Breakers of advanced glycation end products restore large artery properties in experimental diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900015-8

An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900015-8

A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900015-8

Improved arterial compliance by a novel advanced glycation end-product crosslink breaker

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900015-8

Determination of hydroxyproline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900015-8

Pyridoxamine, an inhibitor of advanced glycation reactions, also inhibits advanced lipoxidation reactions. Mechanism of action of pyridoxamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900015-8

The cross-link breaker, N-phenacylthiazolium bromide prevents vascular advanced glycation end-product accumulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900015-8

Glucose-mediated cross-linking of collagen in rat tendon and skin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900015-8

Chelating activity of advanced glycation end-product inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900015-8

Inhibition of collagen synthesis with prolyl 4-hydroxylase inhibitor improves left ventricular function and alters the pattern of left ventricular dilatation after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900015-8

Detoxification of methylglyoxal by the nucleophilic bidentate, phenylacylthiazolium bromide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900015-8

Unexpected carbonyl mobility in aminoketoses: the key to major Maillard crosslinks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900015-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0003-9861(03)00015-8

1 reference

2 December 2017

1 reference